Advertisement
Screener

PHAXIAM Therapeutics S.A. Rental Expense

PHAXIAM Therapeutics S.A. Rental Expense

PHAXIAM Therapeutics S.A. reported Rental Expense of EUR 2.39 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-03-29.

Discontinued › Expense Statement › Operating Expenses

ifrs-full:RentalExpense · last filed 2019-03-29

Period endRental Expense 12 month
2018-12-312.39M EUR
20-F · filed 2019-03-29
2017-12-311.53M EUR
20-F · filed 2019-03-29
2016-12-311.16M EUR
20-F · filed 2019-03-29
2015-12-31767.00K EUR
20-F/A · filed 2018-05-23